Sign in

CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company

Akari Therapeutics Plc

Sign in to watch
Ticker
AKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
EIN
981034922
Phone
(929) 274-7510
Business address
401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
Former names
Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 425 Deal Prospectus/Communication re Business Combination
  3. 8-K Event Material agreement · Regulation FD disclosure
  4. D Other Notice of Sales of Unregistered Securities
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. 424B3 Offering Prospectus
  17. EFFECT Other Notice of Effectiveness
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. EFFECT Other Notice of Effectiveness

Page 12 of 38 · 746 filings